For many women living with lipoedema, the greatest challenge is not always the pain, heaviness or reduced mobility associated with the condition. It is spending years trying to convince healthcare professionals that their symptoms are not simply the result of being overweight.
Despite affecting an estimated 11% of women worldwide, lipoedema remains one of the most under-recognised conditions in women’s health. Diagnosis is frequently delayed, awareness among healthcare professionals varies considerably, and researchers are still working to understand exactly what causes the disease.
As conversations around women’s health inequalities continue to gain momentum, lipoedema is increasingly being recognised as an example of a condition that has spent too long overlooked.
The condition hiding in plain sight
Lipoedema is a chronic disorder of fat distribution that almost exclusively affects women. It typically causes a disproportionate accumulation of fat in the legs, hips, buttocks and sometimes the arms, while the hands and feet remain unaffected.
The condition is thought to affect millions of women globally, yet awareness remains relatively low outside specialist services.
Part of the challenge is that lipoedema can look superficially similar to obesity. Patients often present with enlarged lower limbs and changes in body shape, leading many to be advised to focus solely on weight loss. However, unlike obesity, lipoedema involves abnormal fat tissue that behaves differently and is often accompanied by pain, tenderness, easy bruising and a feeling of heaviness in the affected limbs.
The overlap between obesity and lipoedema can further complicate diagnosis. Many women live with both conditions simultaneously, making it difficult to identify where one ends and the other begins.
As a result, countless patients report years of frustration before receiving an accurate diagnosis.
The diagnosis gap
One of the most significant challenges facing people with lipoedema is the lack of timely recognition.
There is currently no single diagnostic test for the condition. Diagnosis relies on clinical assessment, patient history and the ability of healthcare professionals to recognise characteristic signs and symptoms.
While awareness is growing, many clinicians received little or no formal education about lipoedema during their training. Consequently, patients may move between primary care, weight management services and specialist clinics for years before receiving answers.
For some women, this delay can have a profound impact.
Living with unexplained symptoms often leads to self-blame, particularly when repeated advice centres around diet and exercise. Many patients describe feeling dismissed or misunderstood, creating barriers to future healthcare engagement.
The challenge extends beyond individual experiences. Delayed diagnosis can mean delayed access to symptom management strategies, support services and specialist care, potentially allowing symptoms to progress and quality of life to deteriorate.
A wider women’s health issue
The story of lipoedema also reflects broader conversations taking place across healthcare about women’s health inequalities.
Historically, many conditions that predominantly affect women have experienced delays in recognition, diagnosis and research investment. While significant progress has been made in recent years, patient advocacy groups continue to highlight gaps in awareness and understanding across a range of female-specific and female-predominant conditions.
Lipoedema is no exception.
The condition commonly develops or worsens during periods of hormonal change, including puberty, pregnancy and menopause, suggesting a strong hormonal component. Yet despite this apparent connection, the biological mechanisms driving the disease remain poorly understood.
This uncertainty has contributed to a lack of consistent clinical pathways and varying levels of support depending on where patients live and which healthcare professionals they encounter.
As healthcare systems place greater emphasis on improving women’s health outcomes, there is growing recognition that conditions such as lipoedema deserve greater attention.
What does the research tell us?
Although awareness has increased significantly over the past decade, many fundamental questions about lipoedema remain unanswered.
Researchers are currently investigating the genetic factors that may contribute to the condition, with studies suggesting a hereditary component in many affected families. Scientists are also exploring the role of hormones, inflammatory processes and connective tissue abnormalities in disease development.
At the same time, efforts are underway to improve diagnostic accuracy and develop clearer clinical criteria that can help distinguish lipoedema from obesity and lymphatic disorders.
The challenge is that research funding and large-scale studies have historically been limited. As a result, the evidence base remains less developed than for many other chronic conditions.
Nevertheless, momentum is building. Increased patient advocacy, greater clinical interest and growing international collaboration are helping to expand understanding of the disease and identify potential avenues for earlier diagnosis and more effective treatment.
Improving care and support
While there is currently no cure for lipoedema, experts increasingly advocate for a holistic approach to management that recognises the physical, psychological and social impact of the condition.
This may include exercise programmes designed to improve mobility, compression therapy, pain management strategies, psychological support and weight management interventions where appropriate.
Specialist liposuction procedures have also attracted growing attention as a potential treatment option for carefully selected patients. However, questions remain regarding long-term outcomes, accessibility and consistency of provision.
Importantly, many patient groups argue that improvements in awareness may be just as valuable as new treatments.
Earlier recognition could help reduce years of uncertainty, improve access to support and allow patients to make informed decisions about managing their condition before symptoms become more severe.
Looking ahead
Lipoedema is no longer the little-known condition it once was. Awareness campaigns, patient advocacy organisations and growing clinical interest have all helped bring the disease into sharper focus.
Yet significant challenges remain.
Many women continue to experience lengthy delays in diagnosis, misconceptions persist, and important questions about the causes and progression of the condition remain unanswered.
The growing interest in lipoedema reflects something much larger than a single disease. It highlights the importance of listening to patients, investing in research and ensuring that conditions affecting women receive the attention they deserve.
For healthcare professionals, policymakers and researchers, the challenge now is translating increased awareness into meaningful change.
Because for the women living with lipoedema, recognition is not simply about receiving a diagnosis. It is about finally being understood.
Back to News + Insights